Jan 11, 2023 / 11:45PM GMT
Tessa Thomas Romero - JPMorgan Chase & Co, Research Division - Associate
Welcome, everyone, to the 41st Annual JPMorgan Healthcare Conference. My name is Tess Romero. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Taylor Hanley and Adhiraj Chauhan from the team. Our next presenting company is Atara. And speaking on behalf of the company, we have CEO, Pascal Touchon.
Before I turn it over to Pascal, I just wanted to highlight that post the formal presentation, we will have a Q&A session. There is an ask a question button in the portal. So for those on the webcast, please submit your questions, and I'm happy to ask them on your behalf. We will also be taking live questions, so bring your questions for the session here. With that, I'm going to turn it over to Pascal. Pascal?
Pascal Touchon - Atara Biotherapeutics, Inc. - President, CEO & Director
Thank you, Tessa, and thank you, JPMorgan team, for inviting us to present today. It's a real pleasure to be with you in this room that is protected from the weather. And I hope
Atara Biotherapeutics Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot